The Proof is in the Procurement

Health-tech marketing to health systems gets difficult when the website makes the product easy to understand but the buying evidence hard to find.

The Peterson Health Technology Institute’s 2025 purchasing survey covered 309 U.S. decision-makers responsible for buying or influencing digital health solutions. It found that 79% of health systems had increased digital-health investment over the prior two years, while health systems and health plans put particular weight on a vendor’s track record when selecting solutions.

The Health Management Academy’s 2026 Technology Investment Survey points in the same direction from a different angle. Among 31 senior technology executives at leading U.S. health systems, 71% expected technology budgets to increase in 2026. At the same time, purchasing authority was consolidating: the CIO held final sign-off in 7 of the 11 technology categories the survey examined, and system integration or data sharing was a common trigger for CIO review.

Redesign Health’s 2026 Epic Effect research adds another layer. Its survey of 112 leaders at Epic-based health systems found that Epic often wins because of integration, perceived sufficiency, cost, and lower workflow complexity. When external vendors do win, ease of integration and faster time to value are among the most frequently ranked advantages.

The marketing implication is practical. A health-tech company cannot rely on a feature list and a few customer logos to carry an enterprise buying process. Its website and content need to help a health-system buyer answer questions about risk, implementation, outcomes, and value before those questions become blockers later in the deal.

What a health-system buyer needs to see before the sales call

1. A proven track record in a context that looks relevant

“Trusted by leading health systems” is weak evidence if the buyer cannot tell what those customers actually did with the product. Useful proof gives the buyer enough context to judge whether the result could translate to their environment. That may include:

• The type and size of organization.
• The clinical or operational setting.
• The problem being addressed.
• The scope of the deployment.
• What changed after implementation.
• How the result was measured.
• The time period involved.
• What the customer had to do to implement the product.

PHTI’s purchasing research is useful here because it separates buying interest from evidence. Health systems may continue investing in digital solutions, but they are still evaluating whether the vendor has delivered elsewhere and whether the result is credible. For marketing teams, this means case studies should do more than announce a percentage improvement. They should explain the operating context behind the number.

At Clyck, we use a simple proof-labeling discipline before we repeat an outcome claim: who measured it, what baseline or comparison was used, what period it covers, and whether the customer or an independent party can substantiate it. That is a Clyck framework, not an industry standard, but it prevents a common problem in health-tech marketing: turning a result into a stronger claim than the evidence supports.

2. Integration detail that goes beyond “works with Epic”

Integration is part of the buying case because it affects cost, workflow, implementation time, governance, and who needs to approve the purchase. Redesign Health found that ease of integration appeared in more than 60% of respondents’ ranked reasons for how external vendors can beat Epic. The same research found that ease of integration was also the most frequently cited reason health systems chose Epic over an external option. That means “Epic compatible” is not enough detail for a serious buyer. If the information is accurate and appropriate to publish, a health-tech company should help the buyer understand questions such as:

• Where does the product sit in the clinical or administrative workflow?
• What data moves between systems?
• Which interfaces, APIs, or standards are used?
• Does implementation require custom development?
• What is required from the health system’s IT team?
• How are identity, access, and permissions handled?
• What does testing and go-live normally involve?
• Who supports the integration after launch?

The website does not need to become an implementation manual. It should give the buyer enough information to understand whether the integration story is mature or whether the difficult details have simply been postponed until sales discovery.

3. A believable path from contract to value

Health systems are evaluating the work required after signature, not only the product that appears in the demo. In Redesign Health’s survey, faster time to value ranked near the top of the reasons external vendors can beat Epic. That makes implementation evidence part of marketing evidence. A useful implementation story can explain:

• Typical implementation phases.
• Expected buyer-side roles.
• Training requirements.
• Dependencies that can slow deployment.
• How quickly the customer can begin measuring the intended outcome.
• What support is included during rollout.

The goal is not to promise a universal implementation timeline. Enterprise healthcare deployments vary. The useful marketing move is to make the variables visible and show that the company understands what deployment actually requires.

4. Outcomes with measurement provenance

Health-tech buyers are increasingly being asked to defend the value of a solution after it launches. PHTI’s 2025 survey found a market moving toward measurable clinical and economic outcomes, and its subsequent performance-based contracting work reflects the same pressure. Short contract cycles and recurring reviews give buyers frequent opportunities to reassess whether a product is doing what the vendor said it would do. Health-tech marketing should therefore distinguish among different kinds of evidence instead of treating every number as equivalent. Examples include:

• Customer-measured outcomes.
• Vendor-measured outcomes.
• Independent or peer-reviewed evidence.
• Operational metrics such as time saved or throughput changed.
• Clinical outcomes.
• Financial outcomes.
• Adoption or engagement metrics.

There is nothing inherently wrong with a vendor-measured result. The problem begins when the source and method are unclear. A buyer should be able to tell what the number means, who measured it, and how much confidence to place in it.

5. An economic case with visible assumptions

Health systems do not need every page to contain an ROI calculator. They do need enough information to understand where the economic value is expected to come from. That can mean reduced administrative work, fewer avoidable costs, improved capacity, faster access, increased capture of appropriate revenue, reduced leakage, or another measurable operating effect. The specific mechanism depends on the product.

A credible economic case explains the inputs instead of presenting a dramatic percentage with no path back to the calculation. If the value claim depends on assumptions, show the assumptions. If the result came from one customer environment, say so. If the company is still building the evidence, describe what is being measured rather than inventing certainty.

6. Evidence for the people who actually approve the purchase

A health-system technology purchase rarely belongs to one audience. The Health Management Academy’s 2026 research found that the CIO is the most-cited final decision-maker across many technology categories, but specialized purchases can route differently. Financial technology can center the CFO. Resource-management technology can involve HR leadership. Clinical, operational, security, procurement, legal, and finance stakeholders may enter at different points depending on the product and contract.

Marketing does not need a separate website for every stakeholder. It does need to make the evidence those stakeholders care about findable. A clinical champion may care about workflow and outcomes. IT may care about integration, architecture, and support. Security teams need a clear path to security and compliance information. Finance needs the value logic. Executive sponsors need to understand why the product deserves priority relative to competing investments.

If those answers exist only in sales decks or in the heads of a few employees, the public website is doing less work than it could.

What this means for the health-tech website

A strong health-tech website should help a buyer evaluate the company without requiring three sales calls to uncover basic evidence. The exact architecture will vary, but most companies selling into health systems should be able to support several distinct information needs.

Product and use-case pages

Explain what the product does in the language of the problem and workflow, not only the language of the feature set. Show who uses it, where it sits, and what outcome it is intended to change.

Customer proof

Give case studies enough operating context to be useful. Where permission allows, identify the organization or at least the relevant setting, scope, measurement method, implementation conditions, and outcome.

Integration and implementation

Answer the questions that determine technical and operational fit. If Epic, Oracle Health, athenahealth, or another platform is central to the integration story, explain the relationship accurately rather than relying on logo badges.

Security and compliance

Make it easy for the right buyer to find current security, privacy, compliance, and governance information. Do not use vague claims as a substitute for the actual documentation buyers will request.

Evidence and research

If the company has peer-reviewed research, validation studies, outcomes reports, or economic analyses, give those assets a clear first-party home. Do not make the buyer reconstruct the evidence from press releases, PDFs, conference abstracts, and sales collateral scattered across the site.

How SEO and AI search fit into health-system buyer proof

The same material that helps a buyer evaluate a health-tech vendor also creates stronger search and AI-discovery assets. A buyer or analyst may search for a category problem, an Epic integration question, an implementation concern, a security requirement, a comparison, or evidence that a product works in a specific setting. AI tools can break complex questions into multiple searches and retrieve supporting pages from across the web.

That creates an advantage for companies that publish substantive first-party pages about the issues buyers actually investigate. The goal is not to create a page for every possible prompt. Google’s current guidance on generative search explicitly warns against manufacturing large numbers of query-variant pages and continues to emphasize useful, original, crawlable content built around normal SEO fundamentals. For a health-tech company, the better approach is to build durable pages around the proof buyers repeatedly need:

• What the product changes.
• Where it has worked.
• How it integrates.
• What implementation requires.
• How outcomes are measured.
• How the economics work.
• How the company handles security and compliance.

Those pages can support sales, traditional search, AI search, and buyer due diligence at the same time.

A practical health-system buyer-proof audit

Before adding another feature page, review the site as if you were a health-system buyer trying to decide whether the company deserves a serious evaluation. Can you answer these questions without requesting a demo?

• What type of health system or care setting has used the product?
• What changed after implementation?
• Who measured the result?
• How long did it take to reach the reported outcome?
• What does implementation require from the customer?
• How does the product integrate with the EHR and surrounding systems?
• Where can IT and security teams find relevant documentation?
• What is the economic mechanism behind the ROI claim?
• Which claims are independently validated, customer measured, or vendor measured?
• What makes the product worth adding when the health system may already own an EHR-native alternative?

If the site cannot answer most of those questions, the problem is larger than copywriting. The company has buyer evidence that is missing, fragmented, gated, or not yet developed. That is useful to know because marketing can only communicate proof that exists.

Frequently asked questions

What do health systems look for when evaluating digital health vendors?

Current purchaser research points to several recurring factors: vendor track record, measurable outcomes, integration, implementation burden, security and compliance, economic value, and fit with the health system’s existing technology environment. The weight of each factor varies by product category and organization.

How should a health-tech company market an Epic integration?

Explain what the integration actually does, where the product sits in workflow, what data moves, what the health system must do during implementation, and how the integration is supported. A logo or “Epic compatible” claim does not give a buyer enough information to judge implementation risk.

What should a health-tech case study include?

A useful case study identifies the customer context, problem, deployment scope, implementation conditions, outcome, measurement source, comparison or baseline, and time period. It should make clear whether the result was measured by the customer, the vendor, or an independent party.

Should health-tech marketing lead with features or outcomes?

Feature information still matters, but enterprise buyers need to understand what changes because of the product and what it takes to achieve that change. Marketing should connect capabilities to workflow, implementation, measurable outcomes, and economic value rather than treating the feature list as the proof.

How does GEO change health-tech marketing to health systems?

It increases the value of clear first-party evidence. Search engines and AI systems need accessible pages they can retrieve when users ask questions about products, categories, integrations, outcomes, or implementation. The strongest approach remains useful, authoritative content supported by sound technical SEO rather than speculative AI-search tricks.

Health-tech companies selling into health systems need more than traffic. They need a buyer-facing evidence system that makes the product easier to evaluate before, during, and after the sales process. See how Clyck builds growth systems for health-tech companies.